Severe acute respiratory syndrome

Coronaviruses

Sulforaphane Exhibits Antiviral Activity Against Pandemic SARS-CoV-2 and Seasonal HCoV-OC43 Coronaviruses

Researchers from Johns Hopkins University have made significant findings in the study of COVID-19, identifying sulforaphane as a potential treatment for the virus. According to their research, sulforaphane exhibited antiviral activity against six strains of SARS-CoV-2, including Delta and Omicron, as well as the seasonal coronavirus HCoV-OC43. Sulforaphane was also